Search images on Google Product Monograph
Active Ingredients:
- diphtheria toxoid adsorbed, 2.5 LF/0.5 ML
- tetanus toxoid adsorbed, 5.0 LF/0.5 ML
- pertussis toxoid adsorbed, 8 MCG/0.5 ML
- filamentous haemagglutinin adsorbed, 8 MCG/0.5 ML
- pertactin adsorbed, 2.5 MCG/0.5 ML
- inactivated poliovirus type i, 40 D/0.5 ML
- inactivated poliovirus type ii, 8 D/0.5 ML
- inactivated poliovirus type iii, 32 D/0.5 ML
DIN: 02312557
Dosage Form(s): SUSPENSION
Route(s) of Administration: INTRAMUSCULAR
Schedule: Schedule D
Company: GLAXOSMITHKLINE INC – official site
ATC:
- J07 - VACCINES (ATC, WHO, Wiki)
- J07C - BACTERIAL AND VIRAL VACCINES, COMBINED (ATC, WHO)
- J07CA - Bacterial and viral vaccines, combined (ATC, WHO)
- J07CA02 - DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS (WHO)
Reference brand drug:
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 0.5ML/10X0.5ML
External Links for Boostrix-Polio:
Search on Google
- Boostrix-Polio side effects
- Boostrix-Polio dosage
- diphtheria toxoid adsorbed side effects
- diphtheria toxoid adsorbed dosage
- tetanus toxoid adsorbed side effects
- tetanus toxoid adsorbed dosage
- pertussis toxoid adsorbed side effects
- pertussis toxoid adsorbed dosage
- filamentous haemagglutinin adsorbed side effects
- filamentous haemagglutinin adsorbed dosage
- pertactin adsorbed side effects
- pertactin adsorbed dosage
- inactivated poliovirus type i side effects
- inactivated poliovirus type i dosage
- inactivated poliovirus type ii side effects
- inactivated poliovirus type ii dosage
- inactivated poliovirus type iii side effects
- inactivated poliovirus type iii dosage
Glaxosmithkline Inc
Go to GlaxoSmithKline website to see drug product details. Sometimes you can find boostrix-polio photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.